[Effect of an adrenergic beta-receptor-blocking agent on cardiac rhythm disturbances in experimental barium poisoning].
D000818:Animals; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000188:drug therapy*; D001285:Atropine / Q000494:pharmacology; D001464:Barium / Q000037:antagonists & inhibitors / Q000506:poisoning*; D004285:Dogs; D005260:Female; D008297:Male; D009206:Myocardium / Q000032:analysis; D011188:Potassium / Q000032:analysis; D011433:Propranolol / Q000627:therapeutic use*; D011817:Rabbits; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D013565:Sympatholytics / Q000627:therapeutic use; D013610:Tachycardia / Q000188:drug therapy; D014693:Ventricular Fibrillation / Q000188:drug therapy
D013565:Sympatholytics; D001464:Barium; D001285:Atropine; D012110:Reserpine; D011433:Propranolol; D011188:Potassium
Die Wirkung eines adrenergen beta-Rezeptoren-Blockers auf cardiale Rhythmusstörungen bei experimenteller Vergiftung mit Barium.